BEIJING - As of the end of 2025, over 1.33 billion people were covered by China's basic medical insurance, with the coverage rate remaining stable at around 95 percent.

Enrollment rose by 4.06 million year on year, data from China's National Healthcare Security Administration (NHSA) showed on Monday.

In 2025, the basic medical insurance fund, including maternity insurance, recorded nearly 3.59 trillion yuan (about $520 billion) in revenue and three trillion yuan in expenditure.

In 2025, 7.215 billion outpatient visits were covered by the schemes, up 25.51 percent year-on-year. Inpatient treatments totaled 278 million, down 3.40 percent from a year earlier.

China's medical insurance system continued to help reduce childbirth costs in 2025, said the NHSA, noting that about 260 million people were covered by maternity insurance in 2025, an increase of 6.66 million from a year earlier.

From the beginning of 2025, China began covering certain assisted reproductive treatments, such as egg retrieval and artificial insemination, under medical insurance, and 30 provincial-level regions included pain relief during labor under medical insurance coverage.

In 2025, medical insurance covered over 3 million assisted reproductive treatments, helping more than 1.6 million people across the country, according to NHSA data.

In rural areas, over 99 percent of the low-income population and those lifted out of poverty are now covered by medical insurance in China, said the NHSA.

The updated 2025 national medical insurance drug list added 114 drugs, bringing the total to 3,253.

In 2025, 34.2 billion yuan was recovered, and 1,626 institutions involved in fraud were identified through enhanced oversight of the medical insurance fund.

Authorities used drug-tracking codes to inspect 124,700 medical and pharmaceutical institutions and to punish 39,100 that violated regulations.